Status:
COMPLETED
Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19
Lead Sponsor:
Kufa University
Conditions:
Covid19
Eligibility:
All Genders
18-95 years
Brief Summary
Multicenter retrospective cohort study from June to August 2020 on hospitalized COVID-19 patients admitted to Al-Hakeem and Al-Amal hospital in Al-Najaf Governorate, Iraq, in order to evaluating the e...
Detailed Description
Coronavirus Disease 2019 (COVID-19) is a contagious disease with high rate of fatality caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). In Wuhan, the capital of China's Hubei pr...
Eligibility Criteria
Inclusion
- Adult 18 years old or older.
- COVID-19 confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR).
- hospitalized adult patients with COVID-19.
Exclusion
- Patients with history of alleragy to plasma transfusion.
- Patients with history of autoimmune disease or selective IgA deficiency.
- Patients with suspected coronavirus.
- Patients with incomplete data in his record.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 25 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04764747
Start Date
November 1 2020
End Date
April 25 2021
Last Update
June 2 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Amal Hospital
Najaf, Iraq
2
Al-Hakeem Hospital
Najaf, Iraq